Skip Navigation



Rheumatology Advance Access published online on March 29, 2005

Rheumatology, doi:10.1093/rheumatology/keh613
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
44/7/864    most recent
keh613v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Szalai, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Szalai, A. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org
Received November 18, 2004
Accepted February 22, 2005

Original Papers

Systemic lupus erythematosus in a multiethnic US Cohort (LUMINA). XXX: association between C-reactive protein (CRP) gene polymorphisms and vascular events

A. J. Szalai 1*, G. S. Alarcón 1, J. Calvo-Alén 1, S. M. A. Toloza 1, M. A. McCrory 1, J. C. Edberg 1, G. McGwin Jr1, H. M. Bastian 1, B. J. Fessler 1, L. M. Vilá 2, R. P. Kimberly 1, J. D. Reveille 3, and for the LUMINA Study Group

1 The University of Alabama, Birmingham, AL, USA
2 The University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico, USA
3 The University of Texas Health Science Center at Houston, Houston, TX, USA

* To whom correspondence should be addressed.
A. J. Szalai, E-mail: Alex.Szalai{at}ccc.uab.edu


   Abstract

Objectives. To determine if a polymorphic GTn repeat in the intron of the C-reactive protein (CRP) gene associates with occurrence of vascular arterial events in systemic lupus erythematosus (SLE).

Methods. We performed a nested case-control study on the LUMINA cohort of 546 Hispanic, African-American and Caucasian SLE patients. Twenty-five patients who developed vascular arterial events (i.e. myocardial infarction, angina, coronary artery bypass graft surgery, stroke, claudication, gangrene or significant tissue loss and/or arterial peripheral thrombosis) after enrolment were selected as cases and 32 ethnically matched patients with no previous vascular arterial events served as controls. Their CRP gene GTn polymorphism and plasma CRP was determined.

Results. Patients with vascular events had more severe SLE and were more likely to have plasma CRP in the highest quintile of measured values. The overall distribution of GTn alleles for patients with vascular events had a greater number of the GT20 variant compared with controls [26.0% of alleles (13/50) vs 15.6% (10/64)]. This greater number of GT20 in patients with vascular events was observed for African-Americans [29.2% (7/24) vs 21.0% (8/38)] and Hispanics [33.0% (4/12) vs 0% (0/16)] but not for Caucasians [14.3% (2/14) vs 20.0% (2/10)]. For African-Americans and Hispanics combined (45 patients), the frequency of GT20 in those with vascular events (30.6%, 11/36) was significantly higher than in those without them (14.8%, 8/54) (P<0.05, one-tailed test for difference in proportions). When patients were categorized according to the number of GT20 alleles they carried (thus GT20/GT20, GT20/GTx or GTx/GTx, where x is any allele other than GT20), for both African-Americans and Hispanics the likelihood of vascular arterial events increased in proportion with the GT20 dose, and all GT20-homozygous patients developed vascular arterial events.

Conclusions. The CRP GT20 variant is more likely to occur in African-American and Hispanic SLE patients than in Caucasian ones, and SLE patients carrying the GT20 allele are more likely to develop vascular arterial events.

Keywords: Systemic lupus erythematosus; C-reactive protein.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
LupusHome page
G. S Alarcon
Lessons from LUMINA: a multiethnic US cohort
Lupus, November 1, 2008; 17(11): 971 - 976.
[PDF]


Home page
Eur Heart JHome page
I. Kardys, M. P.M. de Maat, A. G. Uitterlinden, A. Hofman, and J. C.M. Witteman
C-reactive protein gene haplotypes and risk of coronary heart disease: the Rotterdam Study
Eur. Heart J., June 1, 2006; 27(11): 1331 - 1337.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.